The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online December 26, 2006
doi:10.1084/jem.20062131
The Journal of Experimental Medicine, Vol. 204, No. 1, 17-23
The Rockefeller University Press, 0022-1007 $30.00
© 2006 Delbos et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delbos, F.
Right arrow Articles by Reynaud, C.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delbos, F.
Right arrow Articles by Reynaud, C.-A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

DNA polymerase {eta} is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse

Frédéric Delbos1,2, Said Aoufouchi1,2, Ahmad Faili1,2, Jean-Claude Weill1,2, and Claude-Agnès Reynaud1,2

1 Institut National de la Santé et de la Recherche Médicale U783 ("Développement du système immunitaire") and 2 Université Paris René Descartes, Faculté de Médecine René Descartes, Site Necker–Enfants Malades, 75730 Paris Cedex 15, France

CORRESPONDENCE C.-A. Reynaud: reynaud{at}necker.fr OR J.-C. Weill: weill{at}necker.fr

Mutations at A/T bases within immunoglobulin genes have been shown to be generated by a repair pathway involving the DNA-binding moiety of the mismatch repair complex constituted by the MSH2–MSH6 proteins, together with DNA polymerase {eta} (pol {eta}). However, residual A/T mutagenesis is still observed upon inactivation in the mouse of each of these factors, suggesting that the panel of activities involved might be more complex. We reported previously (Delbos, F., A. De Smet, A. Faili, S. Aoufouchi, J.-C. Weill, and C.-A. Reynaud. 2005. J. Exp. Med. 201:1191–1196) that residual A/T mutagenesis in pol {eta}–deficient mice was likely contributed by another enzyme not normally involved in hypermutation, DNA polymerase {kappa}, which is mobilized in the absence of the normal polymerase partner. We report the complete absence of A/T mutations in MSH2–pol {eta} double-deficient mice, thus indicating that the residual A/T mutagenesis in MSH2-deficient mice is contributed by pol {eta}, now recruited by uracil N-glycosylase, the second DNA repair pathway involved in hypermutation. We propose that this particular recruitment of pol {eta} corresponds to a profound modification of the function of uracil glycosylase in the absence of the mismatch repair complex, suggesting that MSH2–MSH6 actively prevent uracil glycosylase from error-free repair during hypermutation. pol {eta} thus appears to be the sole contributor of A/T mutations in the normal physiological context.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase {eta} for A/T
Michael S. Neuberger and Cristina Rada
J. Exp. Med. 2007 204: 7-10. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS